- Home
- SHBI vs RCKT Comparison
SHBI vs RCKT Comparison
Compare SHBI & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SHBI | RCKT |
|---|---|---|
| Founded | 1876 | 1999 |
| Country | United States | United States |
| Employees | N/A | 202 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 636.2M | 401.6M |
| IPO Year | 1997 | N/A |
Fundamental Metrics
Financial Performance| Metric | SHBI | RCKT |
|---|---|---|
| Price | $19.19 | $3.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 14 |
| Target Price | $19.17 | ★ $29.73 |
| AVG Volume (30 Days) | 228.2K | ★ 2.4M |
| Earning Date | 04-23-2026 | 05-04-2026 |
| Dividend Yield | ★ 2.45% | N/A |
| EPS Growth | ★ 34.85 | N/A |
| EPS | ★ 1.78 | N/A |
| Revenue | ★ $20,853,000.00 | N/A |
| Revenue This Year | $8.97 | N/A |
| Revenue Next Year | $6.26 | $64.28 |
| P/E Ratio | $10.97 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $13.67 | $2.19 |
| 52 Week High | $20.68 | $8.26 |
Technical Indicators
Market Signals| Indicator | SHBI | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 51.13 | 39.58 |
| Support Level | $18.88 | $3.32 |
| Resistance Level | $19.31 | $3.52 |
| Average True Range (ATR) | 0.50 | 0.21 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 21.00 | 17.72 |
Price Performance
Historical ComparisonAbout SHBI Shore Bancshares Inc
Shore Bancshares Inc is a financial holding company based in the United States. Through its subsidiaries, it provides consumer and commercial banking products and services, as well as secondary mortgage lending, trust, wealth management, and financial planning services. The group caters to both business and individual clients, offering checking, savings, certificates of deposit, and overnight investment sweep accounts; commercial lending services, including secured and unsecured loans, working capital loans, lines of credit, etc; and safe deposit boxes, debit cards, telephone banking, and other financial products and services.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.